These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 39252401)
1. The Mayo ATTR-CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosis. Bonfioli GB; Tomasoni D; Vergaro G; Castiglione V; Adamo M; Fabiani I; Loghin V; Lombardi CM; Nicolai A; Metra M; Emdin M; Aimo A Eur J Heart Fail; 2024 Sep; ():. PubMed ID: 39252401 [TBL] [Abstract][Full Text] [Related]
2. Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis. Cuddy SA; Datar Y; Ovsak G; Saith S; Murphy SP; Bay CP; Haddad M; Lilleness B; Muralidhar V; Pipilas A; Vuong J; Guardino E; Maurer MS; Ruberg FL; Falk RH; Dorbala S Circ Cardiovasc Imaging; 2022 Nov; 15(11):e014645. PubMed ID: 36378779 [TBL] [Abstract][Full Text] [Related]
3. An echo score raises the suspicion of cardiac amyloidosis in Chinese with heart failure with preserved ejection fraction. Yang H; Li R; Ma F; Wei Y; Liu Y; Sun Y; He X; Zeng H; Yan J; Wang DW; Wang H ESC Heart Fail; 2022 Dec; 9(6):4280-4290. PubMed ID: 36128643 [TBL] [Abstract][Full Text] [Related]
4. A Simple Score to Identify Increased Risk of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction. Davies DR; Redfield MM; Scott CG; Minamisawa M; Grogan M; Dispenzieri A; Chareonthaitawee P; Shah AM; Shah SJ; Wehbe RM; Solomon SD; Reddy YNV; Borlaug BA; AbouEzzeddine OF JAMA Cardiol; 2022 Oct; 7(10):1036-1044. PubMed ID: 36069809 [TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Prediction Model and Score for Transthyretin Cardiac Amyloidosis Diagnosis: T-Amylo. Arana-Achaga X; Goena-Vives C; Villanueva-Benito I; Solla-Ruiz I; Rengel Jimenez A; Gaspar TI; Urreta-Barallobre I; Barge-Caballero G; Seijas-Marcos S; Cabrera E; Garcia-Pavía P; Basurte Elorz MT; Ayestarán NM; Sierra LT; Robledo Iñarritu M; Lozano-Bahamonde A; Escolar-Perez V; Gómez-Ramírez C; Alzola E; Andrés RN; Francisco Matias JL; Limeres Freire J; Armengou Arxe A; Negre Busó M; Piqueras-Flores J; Martínez-Del Río J; Onaindia Gandarias JJ; Rodriguez Sanchez I; Querejeta Iraola R JACC Cardiovasc Imaging; 2023 Dec; 16(12):1567-1580. PubMed ID: 37389511 [TBL] [Abstract][Full Text] [Related]
6. A simple echocardiographic score to rule out cardiac amyloidosis. Aimo A; Chubuchny V; Vergaro G; Barison A; Nicol M; Cohen-Solal A; Castiglione V; Spini V; Giannoni A; Petersen C; Taddei C; Pasanisi E; Chacko L; Martone R; Knight D; Brown J; Martinez-Naharro A; Passino C; Fontana M; Emdin M Eur J Clin Invest; 2021 May; 51(5):e13449. PubMed ID: 33185887 [TBL] [Abstract][Full Text] [Related]
7. Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value. Cipriani A; De Michieli L; Porcari A; Licchelli L; Sinigiani G; Tini G; Zampieri M; Sessarego E; Argirò A; Fumagalli C; De Gaspari M; Licordari R; Russo D; Di Bella G; Perfetto F; Autore C; Musumeci B; Canepa M; Merlo M; Sinagra G; Gregori D; Iliceto S; Perazzolo Marra M; Cappelli F; Rapezzi C JACC CardioOncol; 2022 Nov; 4(4):458-470. PubMed ID: 36444225 [TBL] [Abstract][Full Text] [Related]
9. Non-invasive diagnosis of transthyretin cardiac amyloidosis utilizing typical late gadolinium enhancement pattern on cardiac magnetic resonance and light chains. Slivnick JA; Alvi N; Singulane CC; Scheetz S; Goyal A; Patel H; Sarswat N; Addetia K; Fernandes F; Vieira MLC; Cafezeiro CRF; Carvalhal SF; Simonetti OP; Singh J; Lang RM; Zareba KM; Patel AR Eur Heart J Cardiovasc Imaging; 2023 May; 24(6):829-837. PubMed ID: 36624559 [TBL] [Abstract][Full Text] [Related]
10. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580 [No Abstract] [Full Text] [Related]
11. The Association of Cardiac Biomarkers, the Intensity of Tc99 Pyrophosphate Uptake, and Survival in Patients Evaluated for Transthyretin Cardiac Amyloidosis in the Early Therapeutics Era. Martyn T; Saef J; Hussain M; Ives L; Kiang A; Estep JD; Collier P; Starling RC; Cremer PC; Tang WHW; Hanna M; Jaber WA J Card Fail; 2022 Oct; 28(10):1509-1518. PubMed ID: 35843490 [TBL] [Abstract][Full Text] [Related]
12. Routine 4D Cardiac CT to Identify Concomitant Transthyretin Amyloid Cardiomyopathy in Older Adults with Severe Aortic Stenosis. Bernhard B; Leib Z; Dobner S; Demirel C; Caobelli F; Rominger A; Schütze J; Grogg H; Alwan L; Spano G; Boscolo Berto M; Lanz J; Pilgrim T; Windecker S; Stortecky S; Gräni C Radiology; 2023 Dec; 309(3):e230425. PubMed ID: 38085082 [TBL] [Abstract][Full Text] [Related]
13. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Castaño A; Narotsky DL; Hamid N; Khalique OK; Morgenstern R; DeLuca A; Rubin J; Chiuzan C; Nazif T; Vahl T; George I; Kodali S; Leon MB; Hahn R; Bokhari S; Maurer MS Eur Heart J; 2017 Oct; 38(38):2879-2887. PubMed ID: 29019612 [TBL] [Abstract][Full Text] [Related]
14. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model. Arvanitis M; Koch CM; Chan GG; Torres-Arancivia C; LaValley MP; Jacobson DR; Berk JL; Connors LH; Ruberg FL JAMA Cardiol; 2017 Mar; 2(3):305-313. PubMed ID: 28196196 [TBL] [Abstract][Full Text] [Related]
15. Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis. Aimo A; Fabiani I; Giannoni A; Mandoli GE; Pastore MC; Vergaro G; Spini V; Chubuchny V; Pasanisi EM; Petersen C; Poggianti E; Taddei C; Castiglione V; Latrofa S; Panichella G; Sciaccaluga C; Georgiopoulos G; Passino C; Cameli M; Emdin M Eur Heart J Cardiovasc Imaging; 2022 Dec; 24(1):130-141. PubMed ID: 35292807 [TBL] [Abstract][Full Text] [Related]
16. Novel echocardiographic pixel intensity quantification method for differentiating transthyretin cardiac amyloidosis from light chain cardiac amyloidosis and other phenocopies. Slostad B; Appadurai V; Narang A; Hale S; Lehrer S; Kline A; Bavishi A; Okwuosa I; Jankowski M; Weinberg R; Kansal M; Thomas JD; Shah S Eur Heart J Cardiovasc Imaging; 2024 Oct; 25(11):1601-1611. PubMed ID: 38581424 [TBL] [Abstract][Full Text] [Related]
17. Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis. Papathanasiou M; Jakstaite AM; Oubari S; Siebermair J; Wakili R; Hoffmann J; Carpinteiro A; Hagenacker T; Thimm A; Rischpler C; Kessler L; Rassaf T; Luedike P ESC Heart Fail; 2022 Jun; 9(3):1740-1748. PubMed ID: 35178887 [TBL] [Abstract][Full Text] [Related]
18. Myocardial Work Does Not Have Additional Diagnostic Value in the Assessment of ATTR Cardiac Amyloidosis. Henein MY; Lindqvist P J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640569 [TBL] [Abstract][Full Text] [Related]
19. Clinical clues for suspecting wild-type transthyretin cardiac amyloidosis in patients with monoclonal gammopathy of undetermined significance: a case report. Haga T; Okumura T; Harada Y; Hiraiwa H; Morimoto R; Kaneko S; Kato N; Shinoda M; Murohara T Egypt Heart J; 2024 Jun; 76(1):74. PubMed ID: 38856864 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic Accuracy of Bone Scintigraphy for the Histopathological Diagnosis of Cardiac Transthyretin Amyloidosis-A Retrospective Austrian Multicenter Study. Verheyen N; Ungericht M; Paar L; Danninger K; Schneiderbauer-Porod S; Duca F; Cherouny B; Hoeller V; Ablasser K; Zach D; Kolesnik E; Kiblboeck D; Frick M; Bonderman D; Dierneder J; Ebner C; Weber T; Pölzl G Biomedicines; 2022 Nov; 10(12):. PubMed ID: 36551808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]